Met Life Investment Management, LLC Mannkind Corp Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Mannkind Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 158,481 shares of MNKD stock, worth $879,569. This represents 0.01% of its overall portfolio holdings.
Number of Shares
158,481
Previous 153,371
3.33%
Holding current value
$879,569
Previous $963,000
5.82%
% of portfolio
0.01%
Previous 0.01%
Shares
63 transactions
Others Institutions Holding MNKD
# of Institutions
253Shares Held
155MCall Options Held
1.62MPut Options Held
802K-
Black Rock Inc. New York, NY22.6MShares$125 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.1MShares$89.1 Million0.0% of portfolio
-
State Street Corp Boston, MA9.95MShares$55.2 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY9.16MShares$50.8 Million6.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$48.6 Million0.82% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.43B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...